source
- Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two other Phase 1 studies this year.BioSpace · 1h ago↗ source
- Everything Sprouts recalls alfalfa sprouts over possible E. coli and Salmonella contaminationEverything Sprouts, LLC, a Minneapolis‑based producer, announced a recall of certain lots of its alfalfa sprouts on August 22, 2026. The recall was triggered because the sprouts may be contaminate…